Goldman Sachs Group upgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to a buy rating in a research report sent to investors on Wednesday, 24/7 WallStreet reports. They currently have $160.00 target price on the stock, up from their prior target price of $147.00.
Several other research firms have also recently issued reports on HCA. Deutsche Bank cut Hilton Hotels from a buy rating to a hold rating and set a $92.60 price objective for the company. in a research report on Wednesday, May 1st. They noted that the move was a valuation call. Barclays set a $24.00 price objective on Tenet Healthcare and gave the stock a hold rating in a research report on Wednesday, April 17th. Zacks Investment Research raised GALP ENERGIA SG/ADR from a sell rating to a hold rating in a research report on Monday, May 27th. Jefferies Financial Group set a $158.00 price objective on HCA Healthcare and gave the stock a buy rating in a research report on Wednesday, April 17th. Finally, UBS Group reaffirmed a sell rating on shares of in a research report on Monday, June 24th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and nineteen have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of $149.87.
HCA opened at $141.51 on Wednesday. HCA Healthcare has a 12 month low of $105.28 and a 12 month high of $147.42. The firm has a market cap of $48.44 billion, a PE ratio of 13.59, a price-to-earnings-growth ratio of 1.13 and a beta of 0.80. The business’s fifty day moving average is $129.96.
The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Monday, June 3rd were given a $0.40 dividend. The ex-dividend date was Friday, May 31st. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.13%. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.
In related news, insider Jon M. Foster sold 44,281 shares of the company’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the sale, the insider now directly owns 96,052 shares of the company’s stock, valued at approximately $11,745,238.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 2.70% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Metropolis Capital Ltd raised its stake in HCA Healthcare by 116.4% during the 1st quarter. Metropolis Capital Ltd now owns 238,510 shares of the company’s stock valued at $31,097,000 after acquiring an additional 128,277 shares during the last quarter. Rational Advisors LLC raised its stake in HCA Healthcare by 5,118.2% during the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock valued at $75,000 after acquiring an additional 563 shares during the last quarter. Peak Asset Management LLC raised its stake in HCA Healthcare by 320.9% during the 4th quarter. Peak Asset Management LLC now owns 6,410 shares of the company’s stock valued at $798,000 after acquiring an additional 4,887 shares during the last quarter. National Pension Service raised its stake in HCA Healthcare by 7.6% during the 4th quarter. National Pension Service now owns 314,073 shares of the company’s stock valued at $44,667,000 after acquiring an additional 22,175 shares during the last quarter. Finally, Machina Capital S.A.S. purchased a new stake in HCA Healthcare during the 4th quarter valued at approximately $1,094,000. 70.23% of the stock is owned by hedge funds and other institutional investors.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: Balance Sheet
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.